Back

Cardiopulmonary exercise testing in correlation with magnetic resonance imaging in patients with cardiac amyloidosis

26 April 2024 (12:45 - 13:45)
Organised by: Logo
Congress Presentation Part of: The power of exercise testing for cardiovascular risk assessment Spiroergometry Open Access ESC Preventive Cardiology 2024 European Association of Preventive Cardiology (EAPC)

About the speaker

Photo
Doctor Nikita Ermolaev

Medical University of Vienna, Vienna (Austria)

8 More presentations in this session

Presentation thumbnail
Revisiting the peak breathing reserve < 15% criterion to indicate ventilatory limitation to treadmill incremental cardiopulmonary exercise testing in men and women aged 20 to 80 years
Doctor M. Milani (Hasselt, BE)
Abstract Slides
Presentation thumbnail
External validation and ergometer interchangeability of equations for estimating heart rate at ventilatory thresholds.
Mrs J. Milani (Hasselt, BE)
Abstract Slides
Presentation thumbnail
OUES and mortality in heart failure: a comparison of absolute and percent-predicted values across different equations
Doctor M. Milani (Hasselt, BE)
Abstract Slides
Presentation thumbnail
The usefulness of the tidal Volume difference(Peak-rest) as a prognostic indicator in patients with heart failure with reduced ejection fraction
Doctor S. Moriya (Tokyo, JP)
Abstract Slides
Presentation thumbnail
Cardiopulmonary exercise test registry for patients with obesity: comparison of cardiorespiratory fitness prediction equations and generation of a new predictive model for patients with obesity
Doctor M. Vecchiato (Padova, IT)
Abstract Slides

Access the full session

Session thumbnail
The power of exercise testing for cardiovascular risk assessment

The Event

Event poster

ESC Preventive Cardiology 2024

26 April 2024 12:45 CET
You may be interested in
thumbnail
Congress Presentation
Cardiopulmonary exercise testing in cardiac amyloidosis - a systematic review and meta-analysis
thumbnail
Congress Presentation
NT-proBNP and cardiopulmonary exercise testing parameters for risk stratification in ATTR-CM
thumbnail
Congress Presentation
SGLT2i effects depending on functional capacity in ATTR-CM

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources